|Bid||0.0000 x 3200|
|Ask||1.0700 x 29200|
|Day's Range||0.7731 - 1.1500|
|52 Week Range||0.7731 - 11.9740|
|Beta (3Y Monthly)||4.45|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.
VAUGHAN, ON, Oct. 14, 2019 /CNW/ – CannTrust Holdings Inc. ("CannTrust" or "the Company", TSX: TRST, NYSE: CTST) announced that it continues to make significant progress on its commitment to take any and all actions required to both bring the Company into full regulatory compliance and seek the full reinstatement of its licenses. On September 17, 2019, CannTrust announced that Health Canada had suspended the Company's licenses to produce cannabis and sell cannabis, without affecting the Company's ability to continue cultivating and harvesting cannabis.
VAUGHAN, ON, Oct. 10, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which require the Company to provide bi-weekly updates until such time as the Company is current with its filing obligations under Canadian securities laws. As previously announced, the Company is subject to a management cease trade order ("MCTO") issued by the Ontario Securities Commission. The MCTO prohibits the directors and executive officers of the Company from trading in or acquiring securities of the Company until two full business days after the Company files an interim financial report for the three and six month periods ended June 30, 2019, an interim management's discussion and analysis for the corresponding period and certifications of interim filings.
Even if you're the gambling type, CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST) is not a stock worth taking a chance on.
CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) was recently busted for growing marijuana in unlicensed rooms. Is it still a good stock for your TFSA or RRSP?
CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) stock could surge if management quickly capitalizes on Health Canada’s lenience.
The cannabis sector is characterized extreme volatility. Investors are avoiding Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) and CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) because these marijuana stocks are the riskiest.
Today, President Trump announced that a US-China trade deal could happen earlier than expected. Equities were up, but cannabis stocks were mixed.
CannTrust (CTST) (TRST) was one of the worst performers in the cannabis sector last week. The stock lost almost 19.6% in one week alone.
GW Pharmaceuticals (GWPH) wins EU approval for Epidyolex as an adjunctive treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients aged two years and above.
The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.
Today, the US cannabis markets were trading a little higher than we have seen in the recent past. The Federal Reserve cut interest rates by 25 points.
Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.
VAUGHAN, ON, Sept. 19, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) has received notice from the Alberta Gaming, Liquor and Cannabis Commission (the "AGLC"), the Crown corporation in charge of wholesale distribution of cannabis products to licensed cannabis retailers in Alberta, advising the Company that the AGLC has determined that the Company's products sold to the AGLC will be returned to the Company pursuant to the terms of the Cannabis Supply Agreement between the Company and the AGLC (the "Supply Agreement"). Under the terms of the Supply Agreement, goods sold to the AGLC may be returned to the Company for any reason and the Company will be responsible for the cost of the goods and all expenses related to the return.
CannTrust reported that its license under the Cannabis Act was suspended. The company won't be able to produce cannabis. Will CannTrust fall below $1?.
(Bloomberg) -- CannTrust Holdings Inc., the beleaguered pot company that’s lost 75% of its value after breaching regulations, had its license suspended by the Canadian government.The company won’t be able to sell or produce cannabis, other than cultivating and harvesting existing plants, CannTrust said in a statement Tuesday. The suspension will remain in effect until it can demonstrate the breaches no longer exist or that the suspension was unfounded.Shares tumbled as much as 17% when they resumed trading following the announcement.The suspension won’t change much in the short term as the Vaughan, Ontario based company had already halted all sales and shipments of its products.Health Canada, the government agency responsible for cannabis regulations, told CannTrust that it could potentially address the suspension by taking measures to ensure pot will be produced and distributed only as authorized and to recover cannabis that wasn’t authorized by the license. It would also need to improve key personnel’s knowledge of and compliance with regulations; and to improve record keeping and inventory tracking.CannTrust’s management and board are reviewing the suspension with counsel and other advisers, the company said.The breaches, which included growing pot in unlicensed parts of its greenhouse in Pelham, Ontario, led to the firing of Chief Executive Officer Peter Aceto and a joint investigation by securities regulators and police. The company has hired Greenhill & Co. to explore potential alternatives, including a sale.To contact the reporter on this story: Kristine Owram in Toronto at email@example.comTo contact the editors responsible for this story: Brad Olesen at firstname.lastname@example.org, ;David Scanlan at email@example.com, Jacqueline ThorpeFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.